We use cookies to give you the best possible experience with eirhub.eu. Some are essential for this site to function; others help us understand how you use the site, so we can improve it. We may also use cookies for targeting purposes. Click “Accept all cookies” to proceed as specified, or click “Manage my preferences” to choose the types of cookies you will accept. Cookie policy
Privacy Preference Center
Eirhub and our trusted partners use cookies and similar technologies to access and use your data for the purposes listed below. Please provide your consent for cookie usage on this website. Enable one or more of the cookie types listed below, and then save your preferences. Cookie policy
Manage Consent Preferences
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Active (Inactive)
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Active (Inactive)
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Active (Inactive)
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. Always Active

Market Access

We consult Life Sciences-related organizations on topics related to Market Access regulations, processes, and stakeholders across Europe and Asia

Аdvising companies in their Market Access Pathway

We support organizations on four stages of accessing new markets or niches—from the helicopter view to deep dive into therapeutic or geographical peculiarities:

(1) Early Advice. During the Early Advice stage, we help our clients understand the possibilities of specific countries, identify any potential obstacles to market access and commercialization, map out stakeholders, compare prices, and evaluate important regulatory requirements for pricing, reimbursement, public tendering, and consumer assessment. We provide comprehensive support in understanding and implementing early access programs in the countries of our focus. This stage allows us to take a broad view of a country or therapeutic category.

(2) Market Access Roadmap. Our team creates thorough Market Access Strategic Plans that take into account regulatory requirements, cultural factors, and our clients' marketing strategies. We work closely with the individuals in charge at our clients' companies and use our extensive network of industry professionals, partners, stakeholders, and experts, as well as our 13 years of experience in these markets. We customize cost-efficiency models (CEA, CUA, BIA, costs minimization) according to local requirements. This is an in-depth analysis of a highly specific target market segment.

(3) Pre-Launch. The Pre-Launch stage involves preparing for product launches, including recruiting, talent mapping, developing a functional business model, building effective teams, creating marketing plans, and other pre-sales and marketing elements.

(4) Post-Marketing Consulting. In the Post-Marketing Consulting stage, we offer continuous consulting support on market access topics, such as recruitment and talent mapping of senior and middle-level managers in the life sciences industry across pre-selected regions or countries.

Market Access Strategic Plan
Developing comprehensive roadmaps and strategies to optimize the market access and commercialization of pharmaceuticals, medical devices, and digital health products.
Pricing & Reimbursement
Assessing and strategizing the pricing and reimbursement landscape for pharmaceutical products or medical devices: from pricing analysis to forming pricing strategies and navigating regulatory requirements.
Cost-Efficiency Analyses
Preparation & adaptation of global health economic models (CEA, CUA, BIA,cost-minimization) to local requirements in Ukraine, Poland, Estonia, Latvia, Lithuania, and other CEE countries.
Markets Research
Our market research services for pharma, healthcare, and medtech companies in CEE, Central Asia, and MENA provide comprehensive and customized insights on market dynamics, competitive landscape, regulatory environment, and healthcare system trends.
Stakeholders Interviews
Identification, mapping, recruitment, and interviewing decision-makers, HCPs, patients, and other stakeholders. Forming Advisory Boards and Expert Panels across market segments or therapeutic areas.
Negotiations & Support
Comprehensive market access and regulatory support in pharmaceutical early access programs. Unlock strategic insights for effective navigation of Ukraine's regulatory landscape.
Pre-Market Planning & Assessment
Target market opportunity assessment
Therapeutic area and core markets analyses
Competitors & consumers profiling
Assessing risks and barriers
Interviewing Stakeholders
Long-listing experts
Readiness for interview
Recruiting for interviews
Interviewing KOLs, HCPs, experts, authorities
Marketing Authorization
Product registration routes
Early market access options
Authorities & stakeholders mapping
Timelining & budgeting market entry process
Infrastructural Analysis
Analysis of healthcare structure and governance
Local & regional distribution chain studies
Retail channel and structure by countries
Analysis of flow of goods in a market
National Formulary Listing
Assessing local formulary listing requirements
KOLs and HCPs mapping
Process schemes and timelines
Recruiting and interviewing experts
Demand Forming
Demand forming mechanisms
Market saturation assessment
Assessment of treatment practices
Mapping stakeholders and decision-makers for demand forming activities
Interviewing KOLs, HCPs, experts, authorities
Analysis of Treatment Patterns
Patient journey mapping
Identification of physician influencers and KOLs
Segmentation of Accounts and Targeting
Analysis of epidemiology trends and patterns
Health Technology Assessment
HTA process mapping
Regulatory requirements in HTA
HTA stakeholders identification and interviewing
Forming and discussion with expert groups
Interviewing KOLs, HCPs, experts, authorities
Public Procurement
Studying requirements for public tendering process
Understanding available options
Product-specific options for state purchases
Procedure outlining and stakeholders mapping
Pricing & Reimbursement
Analysis of reimbursement system
Avaialable budgets
Submission process & requirements
Existing pricing levels assessment
Health Technology Assessment
HTA system requirements
Submission process and requirements
Stakeholders mapping
Supply Chain & Sales
Price-forming per segment
Sales & distributions models
Business modelling
Marketing activities planning

Market Access project examples:

Spinal Muscular Atrophy Pricing and Reimbursement Monitoring: A regular monthly report in the P&R status for a focused product covering 12 countries of the region. More details >>
Short Bowel Syndrome—Pre-Market Entry Study: Assessment of market opportunities, regulatory environment, Pricing & Reimbursement status, and map key stakeholders and decision-makers. More details >>
Market Access Pathway for a Schizophrenia Drug: Identification of a winning commercial model for the global biopharmaceutical company on one of the biggest market in the region. More details >>
Road-to-Market Study for 9 CIS countries: Development of market access strategic plans, incl. pricing and reimbursement, market intelligence, and stakeholders mapping for CIS & Central Asian countries. More details >>
Pricing & Reimbursement Assessment for an Epilepsy Drug: Assessment of the pricing & reimbursement environment in the anti-epileptic therapeutic area in one of the CIS markets. More details >>
Market Access Strategy Recommendations: Analysis of major sales channels for innovative and BGx brands in Ukraine, and development of recommendations on the best available options considering the Client's strategy.More details >>

Practice Leaders

Yevgen Brovko
Co-founder, Market Access Partner (Pharmac/Biopharma, MedTech, Digital Health)
Anastasiia Havrysh
Market Access Manager (Pharma, MedTech, Digital Health)
Send us your Request For Proposal
file name

Case Studies

our Brochure